Familial dilated cardiomyopathy
MONDO:0016333A a genetic form of heart disease that occurs when heart (cardiac) muscle becomes thin and weakened in at least one chamber of the heart, causing the open area of the chamber to become enlarged (dilated). As a result, the heart is unable to pump blood as efficiently as usual. To compensate, the heart attempts to increase the amount of blood being pumped through the heart, leading to further thinning and weakening of the cardiac muscle. Over time, this condition results in heart failure.
Also known as: hereditary dilated cardiomyopathy, DCM, dilated cardiomyopathy, familial, hypokinetic dilated cardiomyopathy, familial, idiopathic dilated cardiomyopathy
69 clinical trials for this condition and its sub-types, 7 tagged with Familial dilated cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial dilated cardiomyopathy
-
Leber hereditary optic neuropathy 18 trials
1 sub-type
- Leber optic atrophy and dystonia 0 trials
-
Familial isolated dilated cardiomyopathy 0 trials · 11 incl. sub-types
45 sub-types
- Dilated cardiomyopathy 1HH 5 trials
- Dilated cardiomyopathy 1A 2 trials
- Dilated cardiomyopathy 1C 1 trial
- Dilated cardiomyopathy 1FF 1 trial
- Dilated cardiomyopathy 1P 1 trial
- Dilated cardiomyopathy 3B 1 trial
- Cardiomyopathy, dilated, 2D 0 trials
- Cardiomyopathy, dilated, 2E 0 trials
- Cardiomyopathy, dilated, 2F 0 trials
- Cardiomyopathy, dilated, 2G 0 trials
- Cardiomyopathy, dilated, 2H 0 trials
- Cardiomyopathy, dilated, 2c 0 trials
- Dilated cardiomyopathy 1AA 0 trials
- Dilated cardiomyopathy 1B 0 trials
- Dilated cardiomyopathy 1BB 0 trials
- Dilated cardiomyopathy 1CC 0 trials
- Dilated cardiomyopathy 1D 0 trials
- Dilated cardiomyopathy 1DD 0 trials
- Dilated cardiomyopathy 1E 0 trials
- Dilated cardiomyopathy 1EE 0 trials
- Dilated cardiomyopathy 1G 0 trials
- Dilated cardiomyopathy 1GG 0 trials
- Dilated cardiomyopathy 1H 0 trials
- Dilated cardiomyopathy 1I 0 trials
- Dilated cardiomyopathy 1II 0 trials
- Dilated cardiomyopathy 1JJ 0 trials
- Dilated cardiomyopathy 1K 0 trials
- Dilated cardiomyopathy 1KK 0 trials
- Dilated cardiomyopathy 1L 0 trials
- Dilated cardiomyopathy 1M 0 trials
- Dilated cardiomyopathy 1NN 0 trials
- Dilated cardiomyopathy 1O 0 trials
- Dilated cardiomyopathy 1Q 0 trials
- Dilated cardiomyopathy 1R 0 trials
- Dilated cardiomyopathy 1S 0 trials
- Dilated cardiomyopathy 1U 0 trials
- Dilated cardiomyopathy 1V 0 trials
- Dilated cardiomyopathy 1W 0 trials
- Dilated cardiomyopathy 1X 0 trials
- Dilated cardiomyopathy 1Y 0 trials
- Dilated cardiomyopathy 1Z 0 trials
- Dilated cardiomyopathy 2A 0 trials
- Dilated cardiomyopathy 2B 0 trials
- Left ventricular noncompaction 10 0 trials
- Left ventricular noncompaction 8 0 trials
-
Barth syndrome 5 trials
-
Kearns-Sayre syndrome 5 trials
-
Emery-Dreifuss muscular dystrophy 2 trials · 4 incl. sub-types
4 sub-types
- Autosomal dominant Emery-Dreifuss muscular dystrophy 0 trials · 3 incl. sub-types Sub-types →
- X-linked Emery-Dreifuss muscular dystrophy 1 trial Sub-types →
- Emery-Dreifuss muscular dystrophy 3, autosomal recessive 0 trials
- Scapuloperoneal myopathy 0 trials Sub-types →
-
Histiocytoid cardiomyopathy 3 trials
1 sub-type
- Cardiac lipidosis, familial 0 trials
-
Cardiomyopathy, dilated, 100 0 trials
-
Cardiomyopathy, dilated, 1LL 0 trials
-
Cardiomyopathy, dilated, 1MM 0 trials
-
Cardiomyopathy, dilated, 1QQ 0 trials
-
Cardiomyopathy, dilated, 2I 0 trials
-
Cardiomyopathy, dilated, 2K 0 trials
-
Cardiomyopathy, dilated, 2M 0 trials
-
Cardiomyopathy, dilated, 2j 0 trials
-
Cardiomyopathy, dilated, 2l 0 trials
-
Cardiomyopathy, dilated, 3C 0 trials
-
Dilated cardiomyopathy 1J 0 trials
-
Hypertrophic cardiomyopathy 25 0 trials
-
Myofibrillar myopathy 1 0 trials
Most studied deeper sub-types
-
Experimental gene therapy for rare muscle disease shows early promise but study halted
Disease control Stopped earlyThis study tested a gene therapy called SRP-9003 for people with limb-girdle muscular dystrophy type 2E (LGMD2E), a rare genetic disease that causes muscle weakness. The treatment aimed to deliver a working gene to muscle cells to help them produce a missing protein. Only 6 peopl…
Phase 1/2 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental gene therapy tested for rare muscular dystrophy
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SRP-9004 in just 4 people with limb girdle muscular dystrophy type 2D/R3, a rare muscle-weakening disease. The main goal was to check safety, not effectiveness. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:47 UTC